• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用植入式心脏复律除颤器的多个传感器对房颤危险因素进行动态评估。

Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.

作者信息

La Greca Carmelo, Dell'Aquila Andrea, Prezioso Amedeo, Bertini Matteo, Bianchi Valter, Vitulano Gennaro, Calò Leonardo, Savarese Gianluca, Santobuono Vincenzo Ezio, Dello Russo Antonio, Viscusi Miguel, Santoro Amato, Calvanese Raimondo, Pangallo Antonio, Amellone Claudia, Arena Giuseppe, Campari Monica, Valsecchi Sergio, Boriani Giuseppe, Pecora Domenico

机构信息

Electrophysiology Unit, Cardiology Operating Unit, Fondazione Poliambulanza Hospital, Brescia, Italy.

Cardiology Unit, Sant'Anna University Hospital, University of Ferrara, Italy.

出版信息

Int J Cardiol Heart Vasc. 2025 Jun 20;59:101731. doi: 10.1016/j.ijcha.2025.101731. eCollection 2025 Aug.

DOI:10.1016/j.ijcha.2025.101731
PMID:40606207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12221460/
Abstract

AIMS

The HEAD2TOES schema was introduced to identify modifiable risk factors (RF) for atrial fibrillation (AF), including heart failure (HF), physical inactivity (PA), and sleep apnea (SA). Modern implantable cardioverter-defibrillators (ICDs) can detect SA, assess HF status, and measure daily PA. This study investigates the relationship between atrial high-rate episodes (AHREs) and ICD-detected surrogates for these RF in HF patients.

METHODS AND RESULTS

Data were collected from 411 HF patients with ICDs. The HeartLogic Index measured HF status, Respiratory Disturbance Index (RDI) severe SA (≥30episodes/hour), and accelerometer detected reduced PA (≥1 h/day). Endpoints were daily AHRE burdens ≥ 5 min and ≥ 23 h. Over 26 months of median follow-up, IN-alert-HF state was 13 % of the total observation time, RDI ≥ 30 episodes/h occurred 58 % of time, and 2 % of weekly activity values were ≥ 1 h lower than usual. AHRE burden ≥ 5 min/day occurred in 139 (34 %) patients and ≥ 23 h/day in 68 (17 %). Both IN-alert-state and reduced activity were independently associated with AHRE burden (≥5 min/day and ≥ 23 h/day), while RDI ≥ 30episodes/hour was associated only with AHRE ≥ 5 min/day. We defined a score predicting AHRE burden ≥ 5 min (2HeartLogic_IN-alert + 1RDI ≥ 30episodes/hour + 4Reduction_in_activity ≥ 1 h), and a score predicting AHRE burden ≥ 23 h (1HeartLogic_IN-alert + 2*Reduction_in_activity ≥ 1 h). Lower score levels (AHRE-5 min < 4 and AHRE-23 h < 2) comprised the largest proportion of follow-up duration (98 %), with higher scores linked to higher incidence rate ratios for AHRE (6.75 [95 %CI:1.88-20.16] and 11.46 [95 %CI:3.34-31.72], respectively).

CONCLUSIONS

In HF patients, AHRE occurrence is independently associated with ICD-detected HF status, severe SA, and decreased PA. These ICD-indexes might serve as surrogates for HEAD2TOES RF, aiding in continuous AF risk assessment.

摘要

目的

引入HEAD2TOES模式以识别心房颤动(AF)的可改变风险因素(RF),包括心力衰竭(HF)、身体活动不足(PA)和睡眠呼吸暂停(SA)。现代植入式心脏复律除颤器(ICD)可检测SA、评估HF状态并测量每日PA。本研究调查HF患者中心房高率发作(AHREs)与ICD检测到的这些RF替代指标之间的关系。

方法与结果

收集了411例植入ICD的HF患者的数据。心脏逻辑指数测量HF状态,呼吸紊乱指数(RDI)用于检测严重SA(≥30次/小时),加速度计检测PA降低(≥1小时/天)。终点为每日AHRE负担≥5分钟和≥23小时。在中位随访26个月期间,IN-警报-HF状态占总观察时间的13%,RDI≥30次/小时发生的时间占58%,每周活动值中有2%比平常低≥1小时。139例(34%)患者出现每日AHRE负担≥5分钟,68例(17%)患者出现每日AHRE负担≥23小时。IN-警报状态和活动减少均与AHRE负担(≥5分钟/天和≥23小时/天)独立相关,而RDI≥30次/小时仅与AHRE≥5分钟/天相关。我们定义了一个预测AHRE负担≥5分钟的评分(2×心脏逻辑_IN-警报 + 1×RDI≥30次/小时 + 4×活动减少≥1小时),以及一个预测AHRE负担≥23小时的评分(1×心脏逻辑_IN-警报 + 2×活动减少≥1小时)。较低的评分水平(AHRE-5分钟<4且AHRE-23小时<2)占随访持续时间的最大比例(98%),评分越高,AHRE的发病率比值越高(分别为6.75[95%CI:1.88 - 20.16]和11.46[95%CI:3.34 - 31.72])。

结论

在HF患者中,AHRE的发生与ICD检测到的HF状态、严重SA和PA降低独立相关。这些ICD指标可能作为HEAD2TOES RF的替代指标,有助于持续的AF风险评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23d/12221460/5b256137c095/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23d/12221460/ec63cbb5dd2f/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23d/12221460/295357163787/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23d/12221460/5b256137c095/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23d/12221460/ec63cbb5dd2f/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23d/12221460/295357163787/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23d/12221460/5b256137c095/gr2.jpg

相似文献

1
Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.使用植入式心脏复律除颤器的多个传感器对房颤危险因素进行动态评估。
Int J Cardiol Heart Vasc. 2025 Jun 20;59:101731. doi: 10.1016/j.ijcha.2025.101731. eCollection 2025 Aug.
2
Combination of an implantable defibrillator multi-sensor heart failure index and an apnea index for the prediction of atrial high-rate events.植入式除颤器多传感器心力衰竭指数与呼吸暂停指数联合预测心房高频事件。
Europace. 2023 Apr 15;25(4):1467-1474. doi: 10.1093/europace/euad052.
3
Predictors of Atrial Fibrillation in Heart Failure Patients with Indications for ICD Implantation.有植入式心脏复律除颤器(ICD)植入指征的心力衰竭患者发生心房颤动的预测因素
J Clin Med. 2025 Jun 18;14(12):4358. doi: 10.3390/jcm14124358.
4
Atrial high-rate episode burden and stroke risks for patients with device-detected subclinical atrial fibrillation: A systematic review and meta-analysis.设备检测到的亚临床房颤患者的心房高率发作负担与卒中风险:一项系统评价和荟萃分析
Int J Cardiol. 2023 Jan 15;371:211-220. doi: 10.1016/j.ijcard.2022.09.046. Epub 2022 Oct 13.
5
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
6
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation.多传感器植入式除颤器算法在心房颤动存在时进行心力衰竭监测的性能。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad261.
7
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
8
Results of the Precision Event Monitoring for Patients With Heart Failure Using HeartLogic Study (PREEMPT-HF).使用心脏逻辑研究(PREEMPT-HF)对心力衰竭患者进行精准事件监测的结果。
JACC Heart Fail. 2025 Jun;13(6):973-983. doi: 10.1016/j.jchf.2025.01.028. Epub 2025 Apr 23.
9
Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.无房颤病史患者植入装置后的房性快速性心律失常发作:一项系统评价和荟萃分析
Cardiovasc Drugs Ther. 2022 Oct;36(5):951-958. doi: 10.1007/s10557-021-07209-8. Epub 2021 Jun 5.
10
Left Atrial Size and Left Atrial Volume Index as Predictors of Atrial High-Rate Episodes.左心房大小和左心房容积指数作为心房高速率发作的预测指标。
Pacing Clin Electrophysiol. 2025 Jun;48(6):569-577. doi: 10.1111/pace.15197. Epub 2025 Apr 29.

本文引用的文献

1
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心脏节律协会/心律学会/亚太心脏节律学会/拉丁美洲心脏节律学会专家共识声明:导管和手术消融治疗心房颤动。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae043.
2
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.《2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》2023年聚焦更新
Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
3
Assessment of the efficacy of the electrocardiographic P-wave peak time in predicting atrial high rate episode in patients with cardiac implantable electronic devices.
评估心电图P波峰时间在预测心脏植入式电子设备患者房性高率发作中的有效性。
J Electrocardiol. 2023 Sep-Oct;80:40-44. doi: 10.1016/j.jelectrocard.2023.05.001. Epub 2023 May 6.
4
An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial.一项针对心房颤动患者的运动与身体活动计划:ACTIVE-AF随机对照试验
JACC Clin Electrophysiol. 2023 Apr;9(4):455-465. doi: 10.1016/j.jacep.2022.12.002. Epub 2023 Jan 18.
5
Epidemiology and modifiable risk factors for atrial fibrillation.房颤的流行病学和可改变的危险因素。
Nat Rev Cardiol. 2023 Jun;20(6):404-417. doi: 10.1038/s41569-022-00820-8. Epub 2023 Jan 4.
6
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study.植入式除颤器检测到的睡眠呼吸暂停与心房颤动的关系:DASAP-HF 研究。
J Cardiovasc Electrophysiol. 2022 Jul;33(7):1472-1479. doi: 10.1111/jce.15506. Epub 2022 May 17.
7
Implantable defibrillator-detected heart failure status predicts atrial fibrillation occurrence.植入式除颤器检测到的心力衰竭状态可预测房颤的发生。
Heart Rhythm. 2022 May;19(5):790-797. doi: 10.1016/j.hrthm.2022.01.020. Epub 2022 Jan 20.
8
A VIRTUAL Sleep Apnoea management pathway For the work-up of Atrial fibrillation patients in a digital Remote Infrastructure: VIRTUAL-SAFARI.虚拟睡眠呼吸暂停管理路径用于数字远程基础设施中房颤患者的检查:VIRTUAL-SAFARI。
Europace. 2022 Apr 5;24(4):565-575. doi: 10.1093/europace/euab229.
9
Day-to-day measurement of physical activity and risk of atrial fibrillation.日常体力活动测量与心房颤动风险。
Eur Heart J. 2021 Oct 7;42(38):3979-3988. doi: 10.1093/eurheartj/ehab597.
10
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.